Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes of Patients Presenting with Mild Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study.
Pham T, Serpa Neto A, Pelosi P, Laffey JG, De Haro C, Lorente JA, Bellani G, Fan E, Brochard LJ, Pesenti A, Schultz MJ, Artigas A; LUNG SAFE Investigators* and the European Society of Intensive Care Medicine Trials Group. Pham T, et al. Anesthesiology. 2019 Feb;130(2):263-283. doi: 10.1097/ALN.0000000000002508. Anesthesiology. 2019. PMID: 30499850 Free article.
Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study.
Laffey JG, Bellani G, Pham T, Fan E, Madotto F, Bajwa EK, Brochard L, Clarkson K, Esteban A, Gattinoni L, van Haren F, Heunks LM, Kurahashi K, Laake JH, Larsson A, McAuley DF, McNamee L, Nin N, Qiu H, Ranieri M, Rubenfeld GD, Thompson BT, Wrigge H, Slutsky AS, Pesenti A; LUNG SAFE Investigators; ESICM Trials Group. Laffey JG, et al. Intensive Care Med. 2018 Jan;44(1):157-165. doi: 10.1007/s00134-017-4981-z. Intensive Care Med. 2018. PMID: 29138899
Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 countries (PRoVENT): an international, multicentre, prospective study.
Neto AS, Barbas CSV, Simonis FD, Artigas-Raventós A, Canet J, Determann RM, Anstey J, Hedenstierna G, Hemmes SNT, Hermans G, Hiesmayr M, Hollmann MW, Jaber S, Martin-Loeches I, Mills GH, Pearse RM, Putensen C, Schmid W, Severgnini P, Smith R, Treschan TA, Tschernko EM, Melo MFV, Wrigge H, de Abreu MG, Pelosi P, Schultz MJ; PRoVENT; PROVE Network investigators. Neto AS, et al. Lancet Respir Med. 2016 Nov;4(11):882-893. doi: 10.1016/S2213-2600(16)30305-8. Epub 2016 Oct 4. Lancet Respir Med. 2016. PMID: 27717861
[Anticytokine therapy in sepsis and why it fails].
Chýlek V, Kula R, Holub M, Szturz P, Sklienka P, Máca J. Chýlek V, et al. Among authors: maca j. Klin Mikrobiol Infekc Lek. 2008 Dec;14(6):209-12. Klin Mikrobiol Infekc Lek. 2008. PMID: 19214954 Review. Czech.
Past and Present ARDS Mortality Rates: A Systematic Review.
Máca J, Jor O, Holub M, Sklienka P, Burša F, Burda M, Janout V, Ševčík P. Máca J, et al. Respir Care. 2017 Jan;62(1):113-122. doi: 10.4187/respcare.04716. Epub 2016 Nov 1. Respir Care. 2017. PMID: 27803355 Free article. Review.
Selected Biomarkers Correlate with the Origin and Severity of Sepsis.
Holub M, Džupová O, Růžková M, Stráníková A, Bartáková E, Máca J, Beneš J, Herwald H, Beran O. Holub M, et al. Among authors: maca j. Mediators Inflamm. 2018 Mar 27;2018:7028267. doi: 10.1155/2018/7028267. eCollection 2018. Mediators Inflamm. 2018. PMID: 29769838 Free PMC article.
Calprotectin and calgranulin C serum levels in bacterial sepsis.
Bartáková E, Štefan M, Stráníková A, Pospíšilová L, Arientová S, Beran O, Blahutová M, Máca J, Holub M. Bartáková E, et al. Among authors: maca j. Diagn Microbiol Infect Dis. 2019 Mar;93(3):219-226. doi: 10.1016/j.diagmicrobio.2018.10.006. Epub 2018 Oct 17. Diagn Microbiol Infect Dis. 2019. PMID: 30420210
82 results